CRN pushes back against FDA criticism of dietary supplements
Industry leaders push back against the FDA’s regulatory approach, calling for balanced oversight and stronger enforcement of existing supplement laws.
Industry leaders push back against the FDA’s regulatory approach, calling for balanced oversight and stronger enforcement of existing supplement laws.
Effort aims to celebrate record of self-regulatory innovation.
Other speakers include FDA’s Welch on DSHEA and Deputy Commissioner Jones of Human Foods